Pfizer COVID-19 VACCINE SHOWCASED NO SPECIFIC SAFETY CONCERNS: FDA

Highlights

• The US Food and Drug Administration (FDA) said that the data from 38,000 trial participants involved in the vaccine testing suggest a favorable safety profile

• The group of experts from the FDA are scheduled to meet on Thursday in order discuss an emergency use authorization request for a vaccine

• A 90-year-old woman named Margaret Keenan from the UK became the first person on this pl....